Clinical and pathologic factors that predict lymph node yield from surgical specimens in colorectal cancer: A population-based study

Cancer

Volumn 116, Issue 11, 2010, Pages 2560-2570

  Chou, Joanne F ^a   Row, David ^a   Gonen, Mithat ^a   Liu, Yi Hai ^a   Schrag, Deborah ^a,b   Weiser, Martin R ^a  

^a MEMORIAL SLOAN KETTERING CANCER CENTER   (United States)

^b DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Clinicopathologic factors; Colorectal cancer; End results; Epidemiology; Lymph node yield; Staging; Surveillance

Indexed keywords

ADULT; AGED; ARTICLE; CANCER CLASSIFICATION; CANCER RADIOTHERAPY; CANCER SIZE; COLON CANCER; COLORECTAL CANCER; EARLY CANCER; FEMALE; GEOGRAPHIC DISTRIBUTION; GROUPS BY AGE; HUMAN; HUMAN TISSUE; LYMPH NODE; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM EXAMINATION; MAJOR CLINICAL STUDY; MALE; POPULATION RESEARCH; PREDICTION; PREOPERATIVE TREATMENT; PRIORITY JOURNAL; RECTUM CANCER;

AGE FACTORS; AGED; COLONIC NEOPLASMS; COLORECTAL NEOPLASMS; FEMALE; HUMANS; LYMPH NODES; LYMPHATIC METASTASIS; MALE; MIDDLE AGED; NEOPLASM STAGING; PROGNOSIS; RECTAL NEOPLASMS; SEER PROGRAM; TIME FACTORS;

EID: 77952867243     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.25032     Document Type: Article

References (35)

1. National Cancer Institute. Surveillance Epidemiology and End Results. SEER Stat Fact Sheets. Available at: http://www.seer.cancer.gov/statfacts/html/ colorect.html. Accessed June 27, 2008.
2. National Cancer Institute. Surveillance Epidemiology and End Results. Localized/Regional/Distant Stage Adjustments. Available at: http://www.seer. cancer.gov/seerstat/variables/seer/yr1973-2005/lrd-stage. Accessed June 27, 2008.
3. Chang GJ, Rodriguez-Bigas MA, Skibber JM, Moyer VA. Lymph node evaluation and survival after curative resection of colon cancer: systematic review. J Natl Cancer Inst. 2007:99;433-441. (Pubitemid 47073566)
4. Goldstein NS. Lymph node recoveries from 2427 pT3 colorectal resection specimens spanning 45 years. Am J Surg Pathol. 2002;26:179-189.
5. Le Voyer TE, Sigurdson ER, Hanlon AL, et al. Colon cancer survival is associated with increasing number of lymph nodes analyzed: a secondary survey of Intergroup Trial INT-0089. J Clin Oncol. 2003;21:2912-2919.
6. Swanson RS, Compton CC, Stewart AK, Bland KI. The prognosis of T3N0 colon cancer is dependent on the number of lymph nodes examined. Ann Surg Oncol. 2003;10:65-71.
7. Prandi M, Lionetto R, Bini A, et al. Prognostic evaluation of stage B colon cancer patients is improved by an adequate lymphadenectomy: results of a secondary analysis of a large scale adjuvant trial. Ann Surg Oncol. 2002;235:458-463.
8. Wong J, Bowles B, Bueno R, Shimizu D. Impact of the number of negative nodes on disease-free survival in colorectal cancer patients. Dis Colon Rectum. 2002;45:1341-1348. (Pubitemid 35176044)
9. Chen SL, Bilchik A. More extensive nodal dissection improves survival for stages I to III of colon cancer: a population-based study. Ann Surg. 2006;244:602-610. (Pubitemid 44435772)
10. Cserni G, Vinh-Hung V, Burzykowski T. Is there a minimum number of lymph nodes that should be histologically assessed for a reliable nodal staging of T3N0M0 colorectal carcinomas? J Surg Oncol. 2002;81:63-69.
11. Sarli L, Bader G, Iusco D, et al. Number of lymph nodes examined and prognosis of TNM stage II colorectal cancer. Eur J Cancer. 2004;41:272-279. (Pubitemid 40126960)
12. [No authors listed] NIH Consensus Conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444-1450. (Pubitemid 20331943)
13. National Quality Forum. Appendix A: Specifications of the National Voluntary Consensus Standards for Breast and Colon Cancer. Available at: http://www.qualityforum.org/pdf/cancer/txbreast-colonAppA-Specsvoting01-18-07. Accessed June 27, 2008.
14. Wong JH, Severino R, Honnebier MB, Tom P, Namiki TS. Number of nodes examined and staging accuracy in colorectal carcinoma. J Clin Oncol. 1999;17:2896-2900. (Pubitemid 29415250)
15. Goldstein NS, Sanford W, Coffey M, Layfield LJ. Lymph node recovery from colorectal resection specimens removed for adenocarcinoma: trends over time and a recommendation for a minimum number of lymph nodes to be recovered. Am J Clin Pathol. 1996;106:209-216. (Pubitemid 26277211)
16. Cianchi F, Palomba B, Boddi V, et al. Lymph node recovery from colorectal tumor specimens: recommendation for a minimum number of lymph nodes to be examined. World J Surg. 2002;26:384-389. (Pubitemid 36920420)
17. National Cancer Institute. SEER Training Modules. Anatomy of Colon and Rectum. Available at: http://www.training.seer.cancer.gov/colorectal/anatomy. Accessed June 26, 2008.
18. McCullagh P, Nelder JA, eds. Generalized Linear Models. 2nd ed. London, United Kingdom: Chapman and Hall; 1989.
19. Wright F, Law C, Last L, Khalifa M, Arnaout A, Naseer Z. Lymph node retrieval and assessment in stage II colorectal cancer: a population-based study. Ann Surg Oncol. 2003;10:903-909. (Pubitemid 40486855)
20. Tekkis P, Smith JJ, Heriot AG, Darzi AW, Thompson MR, Stamatakis JD. A national study on lymph node retrieval in resectional surgery for colorectal cancer. Dis Colon Rectum. 2006;49:1673-1683. (Pubitemid 44800484)
21. Baxter NN, Virnig DJ, Rothenberger DA, Morris AM, Jessurun J, Virnig BA. Lymph node evaluation in colorectal cancer patients: a population-based study. J Natl Cancer Inst. 2005;97:219-225. (Pubitemid 40277372)
22. Heald R. A new approach to rectal cancer. Br J Hosp Med. 1979;22:277-281.
23. De la Fuente SG, Manson RJ, Ludwig KA, Mantyh CR. Neoadjuvant chemoradiation for rectal cancer reduces lymph node harvest in proctectomy specimens. J Gastrointest Surg. 2009;13:269-274.
24. Baxter NN, Morris AM, Rothenberger DA, Tepper JE. Impact of preoperative radiation for rectal cancer on subsequent lymph node evaluation: a population-based analysis. Int J Radiat Oncol Biol Phys. 2004;61:426-431.
25. Wichmann M, Muller C, Meyer G, et al. Effect of preoperative radiochemotherapy on lymph node retrieval after resection of rectal cancer. Arch Surg. 2002;137:206-210. (Pubitemid 34142139)
26. Wong SL, Ji H, Hollenbeck BK, Morris AM, Baser O, Birkmeyer JD. Hospital lymph node examination rates and survival after resection for colon cancer. JAMA. 2007;298:2149-2154. (Pubitemid 350106653)
27. Gagliardi AR, Wright F, Khalifa MA, Smith AJ. Multiple factors influence compliance with colorectal cancer staging recommendation: an exploratory study [serial online]. BMC Health Serv Res. 2008;8:34. (Pubitemid 351432877)
28. MacFarlane JK, Ryall RD, Heald RJ. Mesorectal excision for rectal cancer. Lancet. 1993;341:457-460.
29. Enker WE. Potency, cure, and local control in the operative treatment of rectal cancer. Arch Surg. 1992;127:1396-1401.
30. Enker WE, Thaler HT, Cranor ML, Polyak T. Total mesorectal excision in the operative treatment of carcinoma of the rectum. J Am Coll Surg. 1995;181:335-346.
31. Murty M, Enker WE, Martz J. Current status of total mesorectal excision and autonomic nerve preservation in rectal cancer. Semin Surg Oncol. 2000;19:321-328. (Pubitemid 32186922)
32. National Comprehensive Cancer Network (NCCN). NCCN Clinical Practice Guidelines in Oncology. Principles of Pathologic Review for Colon and Rectal Cancer. Available at: www.ncn.org/professionals/physician-gls/PDF/rectal www.nccn.org/professionals/physician-gls/PDF/colon. Accessed June 23, 2008.
33. Herrera L, Villarreal JR. Incidence of metastases from rectal adenocarcinoma in small lymph nodes detected by a clearing technique. Dis Colon Rectum. 1992;35:783-788.
34. Andreola S, Leo E, Belli F, et al. Manual dissection of adenocarcinoma of the lower third of the rectum specimens for detection of lymph node metastases smaller than 5 mm. Cancer. 1996;77:607-612. (Pubitemid 26055383)
35. West NP, Morris EJ, Rotimi O, Cairns A, Finan PJ, Quirke P. Pathology grading of colon cancer surgical resection and its association with survival: a retrospective observational study. Lancet Oncol. 2008;9:815-817.